Senn 2007.

Trial name or title
Methods	RCT; Unit of allocation: Patient
Participants	Cancer patients who went through initial treatment Setting / country: Health Network / France and United Kingdom Type of cancer: Prostate, breast, colorectal Phase of care: Surveillance Planned sample size at randomisation: 1200
Interventions	GP follow‐up: a trained GP will be responsible for follow‐up with possible referral to the specialist physician (and its team) when requested. The procedure of surveillance is exactly the same used in the control group. The GP and the specialist give relevant information to each other within the 15 days following each consultation Control: Usual follow‐up by the specialist physician (and their team).
Outcomes	Patient: Satisfaction, QoL, iatrogenic effects Professional: Physician's (SG and specialist) perception or the surveillance performed in the study, satisfaction Process: Adequacy between the reference protocol and the carried‐out surveillance (performed exams, date of exam versus forecast schedule), presence of relevant information according to the surveillance, costs
Starting date
Contact information
Notes	Planned study duration: 24 months